Authors Kushner & colleagues shook the landscape of pharmacological weight loss with their findingsover one third of the 1,961 participants lost more than 20% of their body weight after 68 weeks
In studies, after 52 weeks, participants on the highest dose of Mounjaro (15 mg per week): Lowered their total cholesterol by about 5.6 percent Lowered their triglycerides by 22.5 percent Lowered their LDL (bad) cholesterol by 7.9 percent Lowered their VLDL cholesterol by 21.8 percent Increased their HDL (good) cholesterol by 10.8 percent Additionally, a meta-analysis (analysis of data from several clinical trials) from The Lancet found that Ozempic lowered cardiovascular risk and even decreased the risk of death in people with diabetes and heart disease
These drugs can cross the BBB, reduce insulin resistance, stabilize mitochondrial function, and increase the survival and functional state of neurons
Clinical Trials Novo Nordisk has shared topline results from the COMBINE 3 phase 3a trial of once-weekly IcoSema, a fixed-ratio combination treatment consisting of basal insulin icodec and semaglutide
But if you are sensitive to side effects, currently in the dose-escalation phase, or already experiencing tirzepatide fatigue or GI symptoms, the extra residual drug could amplify those effects temporarily